Avidity Biosciences
142 hedge funds and large institutions have $522M invested in Avidity Biosciences in 2023 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 62 increasing their positions, 40 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
142
Holders Change
-1
Holders Change %
-0.7%
% of All Funds
2.26%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
18
Increased
62
Reduced
40
Closed
19
Calls
$601K
Puts
$14K
Net Calls
+$587K
Net Calls Change
+$1.02M
Top Buyers
| 1 |
1
Millennium Management
New York
|
$4.72M |
| 2 |
2
Adage Capital Partners
Boston,
Massachusetts
|
$8.29M |
| 3 |
3
Fidelity Investments
Boston,
Massachusetts
|
$70.9M |
| 4 |
4
JPMorgan Chase & Co
New York
|
$6.19M |
| 5 |
CC
5
Casdin Capital
New York
|
$7.98M |
